Project Grant R41DA064319
Award Date 6/15/26
Completion Date 5/31/27
Dollars Obligated $314K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Massachusetts, USA
Similar Awards
- Federal Project Grant Award Summary Funding Agency: National Institute on Drug Abuse (NIDA) Federal Grant Program: Drug Use and Addiction Research Programs (CFDA 93.279) Award Amount: $398,580 Award Date: June 15, 2026 Project Completion: May 31, 2027 Awardee: Doro Mind Inc. Doro Mind Inc. will develop a digital platform designed to address adverse effects resulting from non-disordered drug use in individuals with serious mental illness (SMI). The platform will incorporate two primary...
- Federal Grant Award Summary Addinex Technologies, Inc. received a $613,056 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop an enhanced medication adherence and monitoring system for decentralized clinical trials in substance use disorder (SUD) treatment. The award, effective September 1, 2025 through August 31, 2026, funds the adaptation of Addinex's existing medication management platform to enable...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $305,358 to Thrive Genetics, Inc. under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 1, 2026, for a Phase I Small Business Technology Transfer (STTR) project. The award funds the development of an interactive, web-based personalized prevention program for substance use disorder (SUD) risk, developed through a collaboration between Thrive Genetics, Inc. and Dr. Danielle Dick of the Rutgers...
- Federal Grant Award Summary Partnership To End Addiction received a $453,750 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective March 15, 2026, through February 29, 2028. The award funds development and evaluation of HALO (Helping Affected Loved Ones), an artificial intelligence-powered chatbot designed to deliver evidence-based, real-time support to concerned significant others (CSOs)—primarily parents...
- Federal Grant Award Summary Biosyft Inc. received a $301,390 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective July 1, 2026, through June 30, 2027. The company is developing and validating an artificial intelligence (AI)-driven behavioral analysis platform designed to detect addiction-related reward signatures in rodent models through automated multi-view analysis. The platform addresses critical...
- Federal Grant Award Summary Pillsmart Inc. received a $399,993 Phase I Small Business Innovation Research (SBIR) project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective June 1, 2026 through May 31, 2027. The company is developing LEVL, a clinical decision support (CDS) system designed to enable early detection of relapse risk among adolescents with substance use disorders (SUDs). The platform integrates...
- Federal Grant Award Summary Biomotivate LLC received a $613,744 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the PEACE Platform (Personalized Evocative Audiovisual Content for Everyone), a precision medicine tool designed to support individuals with opioid use disorders (OUDs). The platform leverages generative artificial intelligence, machine learning algorithms, and physiological data...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UCLA a $376,398 Project Grant effective April 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate a digital therapeutic intervention for individuals with comorbid anxiety disorders and alcohol/cannabis use disorders. The primary deliverable is Anxiety Management Treatment for Substance Use Disorders (AMT/SUD), a mobile application-based intervention that adapts...
- Federal Project Grant Summary Ksana Health Inc. received a $812,902 Project Grant award on July 15, 2025, from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the VIRA mobile application—a smartphone-based, just-in-time adaptive intervention platform for opioid use disorder (OUD) treatment. This Phase I Small Business Innovation Research (SBIR) project extends VIRA's existing mental health capabilities to...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Washington a $668,939 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective June 1, 2026, through March 31, 2031, to conduct a hybrid effectiveness-implementation study testing the mHealth Incentivized Adherence Plus Patient Navigation (MIAPP) intervention. This research addresses the critical public health need to improve linkage and adherence to outpatient buprenorphine...